Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The escalating global health crisis of antibiotic resistance, driven by the rapid emergence of multidrug-resistant (MDR) bacterial pathogens, necessitates urgent and innovative countermeasures. This review comprehensively examines the diverse mechanisms employed by bacteria to evade antibiotic action, including alterations in cell membrane permeability, efflux pump overexpression, biofilm formation, target site modifications, and the enzymatic degradation of antibiotics. Specific focus is given to membrane transport systems such as ATP-binding cassette (ABC) transporters, resistance–nodulation–division (RND) efflux pumps, major facilitator superfamily (MFS) transporters, multidrug and toxic compound extrusion (MATE) systems, small multidrug resistance (SMR) families, and proteobacterial antimicrobial compound efflux (PACE) families. Additionally, the review explores the global burden of MDR pathogens and evaluates emerging therapeutic strategies, including quorum quenching (QQ), probiotics, postbiotics, synbiotics, antimicrobial peptides (AMPs), stem cell applications, immunotherapy, antibacterial photodynamic therapy (aPDT), and bacteriophage. Furthermore, this review discusses novel antimicrobial agents, such as animal-venom-derived compounds and nanobiotics, as promising alternatives to conventional antibiotics. The interplay between clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) in bacterial adaptive immunity is analyzed, revealing opportunities for targeted genetic interventions. By synthesizing current advancements and emerging strategies, this review underscores the necessity of interdisciplinary collaboration among biomedical scientists, researchers, and the pharmaceutical industry to drive the development of novel antibacterial agents. Ultimately, this comprehensive analysis provides a roadmap for future research, emphasizing the urgent need for sustainable and cooperative approaches to combat antibiotic resistance and safeguard global health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced drug uptake, methylation of the 16S rRNA by methyltransferases, modifications to the 30S ribosomal subunit, and the activation of efflux pumps collectively contribute to bacterial survival in antibiotic-rich environments [232,233].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [232]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Research works printed but not linked: 199
- Zhao, 2021, Glutamine Promotes Antibiotic Uptake to Kill Multidrug-Resistant Uropathogenic Bacteria, Sci. Transl. Med., 13, eabj0716, 10.1126/scitranslmed.abj0716 · DOI · Paper page
- Islam, M.A., Islam, M.R., Khan, R., Amin, M.B., Rahman, M., Hossain, M.I., Ahmed, D., Asaduzzaman, M., and Riley, L.W. (2022). Prevalence, Etiology and Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Dhaka, Bangladesh. PLoS ONE, 17. · DOI
- Safdar, N., Zahra, A., Komal, S., Ul Ain, Q., and Mazhar, M. (2023). The Trend of Antibiotic Resistance In the Era of COVID-19 and Its Trailing. SSRN J. · doi:10.2139/ssrn.4511574
- El-Sapagh, S., El-Shenody, R., Pereira, L., and Elshobary, M. (2023). Unveiling the Potential of Algal Extracts as Promising Antibacterial and Antibiofilm Agents against Multidrug-Resistant Pseudomonas aeruginosa: In Vitro and In Silico Studies Including Molecular Docking. Plants, 12. · DOI
- Osei Sekyere, J., Kerdsin, A., Chopjitt, P., and Wendling, C.C. (2023). Editorial: Community Series—Characterization of Mobile Genetic Elements Associated with Acquired Resistance Mechanisms, Volume II. Front. Microbiol., 14. · DOI
- Günther, T., Kramer-Schadt, S., Fuhrmann, M., and Belik, V. (2022). Environmental Factors Associated with the Prevalence of ESBL/AmpC-Producing Escherichia coli in Wild Boar (Sus scrofa). Front. Vet. Sci., 9. · DOI
- Lee, 2022, Membrane Vesicles from Antibiotic-Resistant Staphylococcus aureus Transfer Antibiotic-Resistance to Antibiotic-Susceptible Escherichia coli, J. Appl. Microbiol., 132, 2746, 10.1111/jam.15449 · DOI
- Terefinko, 2023, Removal of Clinically Significant Antibiotics from Aqueous Solutions by Applying Unique High-Throughput Continuous-Flow Plasma Pencil and Plasma Brush Systems, Chem. Eng. J., 452, 139415, 10.1016/j.cej.2022.139415 · DOI
- Zhou, 2022, A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China, Antimicrob. Agents Chemother., 66, e02188-21, 10.1128/aac.02188-21 · DOI
- Alam, 2021, Prevalence of Multidrug Resistance Bacterial Isolates from Infected Wound Patients in Dhaka, Bangladesh: A Cross-Sectional Study, Int. J. Surg. Open, 28, 56, 10.1016/j.ijso.2020.12.010 · DOI
- Nocera, F.P., Ambrosio, M., Fiorito, F., Cortese, L., and De Martino, L. (2021). On Gram-Positive- and Gram-Negative-Bacteria-Associated Canine and Feline Skin Infections: A 4-Year Retrospective Study of the University Veterinary Microbiology Diagnostic Laboratory of Naples, Italy. Animals, 11. · DOI
- Wang, 2019, Impact of Antimicrobial Stewardship Managed by Clinical Pharmacists on Antibiotic Use and Drug Resistance in a Chinese Hospital, 2010–2016: A Retrospective Observational Study, BMJ Open, 9, e026072, 10.1136/bmjopen-2018-026072 · DOI · Paper page
- Pulingam, 2021, Antimicrobial Resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome, Eur. J. Pharm. Sci., 170, 106103, 10.1016/j.ejps.2021.106103 · DOI · Paper page
- Shrestha, 2018, Enumerating the Economic Cost of Antimicrobial Resistance per Antibiotic Consumed to Inform the Evaluation of Interventions Affecting Their Use, Antimicrob. Resist. Infect. Control, 7, 98, 10.1186/s13756-018-0384-3 · DOI · Paper page
- Li, 2022, Bacterial Resistance to Antibacterial Agents: Mechanisms, Control Strategies, and Implications for Global Health, Sci. Total Environ., 860, 160461, 10.1016/j.scitotenv.2022.160461 · DOI
- Hosny, S., Elshobary, M.E., and El-Sheekh, M.M. (2025). Unleashing the Power of Microalgae: A Pioneering Path to Sustainability and Achieving the Sustainable Development Goals. Environ. Sci. Pollut. Res., 1–31. · DOI
- Theuretzbacher, 2020, Critical Analysis of Antibacterial Agents in Clinical Development, Nat. Rev. Microbiol., 18, 286, 10.1038/s41579-020-0340-0 · DOI · Paper page
- Outterson, 2021, Estimating the Appropriate Size of Global Pull Incentives For Antibacterial Medicines: Study Examines Global Antibacterial Pull Incentives, Health Aff., 40, 1758, 10.1377/hlthaff.2021.00688 · DOI
- Balasegaram, 2020, Antibiotic Development—Economic, Regulatory and Societal Challenges, Nat. Rev. Microbiol., 18, 267, 10.1038/s41579-019-0293-3 · DOI · Paper page
- Blind, K. (2023). The Overall Impact of Economic, Social and Institutional Regulation on Innovation: An Update. Handbook of Innovation and Regulation, Edward Elgar Publishing. · doi:10.4337/9781800884472.00020
- Pierce, 2022, Post-COVID-19 Syndrome, Nurs. Res., 71, 164, 10.1097/NNR.0000000000000565 · DOI
- Smith, 2023, Bacterial Defences: Mechanisms, Evolution and Antimicrobial Resistance, Nat. Rev. Microbiol., 21, 519, 10.1038/s41579-023-00877-3 · DOI · Paper page
- Sakagianni, A., Koufopoulou, C., Koufopoulos, P., Kalantzi, S., Theodorakis, N., Nikolaou, M., Paxinou, E., Kalles, D., Verykios, V.S., and Myrianthefs, P. (2024). Data-Driven Approaches in Antimicrobial Resistance: Machine Learning Solutions. Antibiotics, 13. · DOI
- Abushaheen, 2020, Antimicrobial Resistance, Mechanisms and Its Clinical Significance, Disease-a-Month, 66, 100971, 10.1016/j.disamonth.2020.100971 · DOI · Paper page
- Andrade, 2023, Serratia marcescens Antibiotic Resistance Mechanisms of an Opportunistic Pathogen: A Literature Review, PeerJ, 11, e14399, 10.7717/peerj.14399 · DOI
- Lade, H., and Kim, J.-S. (2023). Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review. Antibiotics, 12. · DOI · Paper page
- Tierney, 2022, Stochastic Activation of a Family of TetR Type Transcriptional Regulators Controls Phenotypic Heterogeneity in Acinetobacter baumannii, PNAS Nexus, 1, pgac231, 10.1093/pnasnexus/pgac231 · DOI
- Esau, V.C.-Z. (2023). Structure-Activity Relationship Between Klebsiella pneumoniae β-Lactamase CTX-M-15 and Selected β-Lactam Antibiotics: Evaluating the Binding Site Promiscuity. [Master’s Thesis, University of the Witwatersrand].
- Miller, 2016, Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century, Infect. Dis. Clin., 30, 415
- Lewis, 2017, New Approaches to Antimicrobial Discovery, Biochem. Pharmacol., 134, 87, 10.1016/j.bcp.2016.11.002 · DOI
- Singh, 2022, Regulation of Small RNA-Mediated High Temperature Stress Responses in Crop Plants, Plant Cell Rep., 41, 765, 10.1007/s00299-021-02745-x · doi:10.1007/s00299-021-02745-x
- Rodríguez-Núñez, K., Cortés-Monroy, A., Serey, M., Ensari, Y., Davari, M.D., Bernal, C., and Martinez, R. (2023). Modulating Substrate Specificity of Rhizobium Sp. Histamine Dehydrogenase Through Protein Engineering for Food Quality Applications. Molecules, 28. · doi:10.3390/molecules28093748
- Kakoullis, L., Papachristodoulou, E., Chra, P., and Panos, G. (2021). Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions. Antibiotics, 10. · DOI · Paper page
- De Gaetano, G.V., Lentini, G., Famà, A., Coppolino, F., and Beninati, C. (2023). Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps. Antibiotics, 12. · DOI
- Scoffone, V.C., Trespidi, G., Barbieri, G., Arshad, A., Israyilova, A., and Buroni, S. (2025). The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It. Antibiotics, 14. · DOI
- Zakaria, N.F.S., Yahya, M.F.Z.R., and Jamil, N.M. (2023). Multiple Bacterial Strategies to Survive Antibiotic Pressure: A Review. Preprints. · DOI
- Belay, W.Y., Getachew, M., Tegegne, B.A., Teffera, Z.H., Dagne, A., Zeleke, T.K., Abebe, R.B., Gedif, A.A., Fenta, A., and Yirdaw, G. (2024). Mechanism of Antibacterial Resistance, Strategies and Next-Generation Antimicrobials to Contain Antimicrobial Resistance: A Review. Front. Pharmacol., 15. · DOI · Paper page
- Henderson, 2019, Coupling Efficiency of Secondary Active Transporters, Curr. Opin. Biotechnol., 58, 62, 10.1016/j.copbio.2018.11.005 · DOI
- Li, 2023, Identification and Characterization of a Novel Major Facilitator Superfamily Efflux Pump, SA09310, Mediating Tetracycline Resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 67, e01696-22, 10.1128/aac.01696-22 · DOI
- Nag, 2021, A Major Facilitator Superfamily (MFS) Efflux Pump, SCO4121, from Streptomyces coelicolor with Roles in Multidrug Resistance and Oxidative Stress Tolerance and Its Regulation by a MarR Regulator, Appl. Environ. Microbiol., 87, e02238-20, 10.1128/AEM.02238-20 · DOI
- Vrancianu, C.O., Gheorghe, I., Czobor, I.B., and Chifiriuc, M.C. (2020). Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms, 8. · DOI · Paper page
- Corral, 2019, Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978, Antimicrob. Agents Chemother., 63, e02190-18, 10.1128/AAC.02190-18 · doi:10.1128/aac.02190-18
- Teng, D., and Voth, G.A. (2023). Ligand Binding by the Small Multidrug-Resistant Transporter EmrE. Biophys. J., 122. · doi:10.1016/j.bpj.2022.11.2183
- Guérin, F., Galimand, M., Tuambilangana, F., Courvalin, P., and Cattoir, V. (2014). Overexpression of the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is Driven by Inactivation of Its Local Repressor FepR. PLoS ONE, 9. · DOI
- Miyauchi, 2017, Structural Basis for Xenobiotic Extrusion by Eukaryotic MATE Transporter, Nat. Commun., 8, 1633, 10.1038/s41467-017-01541-0 · DOI
- Kim, J., Cater, R.J., Choy, B.C., and Mancia, F. (2021). Structural Insights into Transporter-Mediated Drug Resistance in Infectious Diseases. J. Mol. Biol., 433. · DOI · Paper page
- Stephen, J., Lekshmi, M., Ammini, P., Kumar, S.H., and Varela, M.F. (2022). Membrane Efflux Pumps of Pathogenic Vibrio Species: Role in Antimicrobial Resistance and Virulence. Microorganisms, 10. · DOI
- Hassan, 2018, Pacing across the Membrane: The Novel PACE Family of Efflux Pumps Is Widespread in Gram-Negative Pathogens, Res. Microbiol., 169, 450, 10.1016/j.resmic.2018.01.001 · DOI · Paper page
- Javed, W. (2020). Study of the Conformational States of a Bacterial Multidrug ABC Transporter BmrA. [Ph.D. Thesis, Université Grenoble Alpes].
- Migliaccio, A., Esposito, E.P., Bagattini, M., Berisio, R., Triassi, M., De Gregorio, E., and Zarrilli, R. (2022). Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606. Front. Microbiol., 12. · DOI
- Labby, 2016, Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives, Medchemcomm, 7, 11, 10.1039/C5MD00344J · DOI · Paper page
- Nikaido, 2018, RND Transporters in the Living World, Res. Microbiol., 169, 363, 10.1016/j.resmic.2018.03.001 · DOI · Paper page
- Yamasaki, S., Zwama, M., Yoneda, T., Hayashi-Nishino, M., and Nishino, K. (2023). Drug Resistance and Physiological Roles of RND Multidrug Efflux Pumps in Salmonella enterica, Escherichia coli and Pseudomonas aeruginosa: This Article Is Part of the Antimicrobial Efflux Collection. Microbiology, 169. · DOI
- Lyu, 2022, Structural Basis of Peptide-Based Antimicrobial Inhibition of a Resistance-Nodulation-Cell Division Multidrug Efflux Pump, Microbiol. Spectr., 10, e02990-22, 10.1128/spectrum.02990-22 · DOI
- Ghai, I. (2024). Electrophysiological Insights into Antibiotic Translocation and Resistance: The Impact of Outer Membrane Proteins. Membranes, 14. · DOI
- Ghai, I. (2023). A Barrier to Entry: Examining the Bacterial Outer Membrane and Antibiotic Resistance. Appl. Sci., 13. · DOI
- Elshobary, M.E., Ebaid, R., Alquraishi, M., and Ende, S.S. (2025). Synergistic Microalgal Cocultivation: Boosting Flocculation, Biomass Production, and Fatty Acids Profile of Nannochloropsis oculata and Phaeodactylum tricornutum. Biomass Bioenergy, 193. · DOI
- Ahsan, A., Thomas, N., Barnes, T.J., Subramaniam, S., Loh, T.C., Joyce, P., and Prestidge, C.A. (2024). Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms. Pharmaceutics, 16. · DOI
- Parvin, N., Joo, S.W., and Mandal, T.K. (2025). Nanomaterial-Based Strategies to Combat Antibiotic Resistance: Mechanisms and Applications. Antibiotics, 14. · DOI · Paper page
- Chaudhari, R., Singh, K., and Kodgire, P. (2022). Biochemical and Molecular Mechanisms of Antibiotic Resistance in Salmonella spp.. Res. Microbiol., 174. · DOI
- Mahdally, N.H., George, R.F., Kashef, M.T., Al-Ghobashy, M., Murad, F.E., and Attia, A.S. (2021). Staquorsin: A Novel Staphylococcus aureus Agr-Mediated Quorum Sensing Inhibitor Impairing Virulence In Vivo Without Notable Resistance Development. Front. Microbiol., 12. · DOI
- Gbian, D.L., and Omri, A. (2021). The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics Against Pseudomonas aeruginosa. Pharmaceutics, 13. · doi:10.3390/pharmaceutics13040577
- Lopez-Fernandez, M., Westmeijer, G., Turner, S., Broman, E., Ståhle, M., Bertilsson, S., and Dopson, M. (2023). Thiobacillus as a Key Player for Biofilm Formation in Oligotrophic Groundwaters of the Fennoscandian Shield. npj Biofilms Microbiomes, 9. · DOI
- Li, 2021, Biological and Physiochemical Methods of Biofilm Adhesion Resistance Control of Medical-Context Surface, Int. J. Biol. Sci., 17, 1769, 10.7150/ijbs.59025 · DOI
- Xu, Y., Zeng, C., Wen, H., Shi, Q., Zhao, X., Meng, Q., Li, X., and Xiao, J. (2023). Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation. Pharmaceuticals, 16. · DOI
- Fatima, M., Amin, A., Alharbi, M., Ishtiaq, S., Sajjad, W., Ahmad, F., Ahmad, S., Hanif, F., Faheem, M., and Khalil, A.A.K. (2023). Quorum Quenchers from Reynoutria japonica in the Battle against Methicillin-Resistant Staphylococcus aureus (MRSA). Molecules, 28. · DOI
- Shi, Q., Wen, H., Xu, Y., Zhao, X., Zhang, J., Li, Y., Meng, Q., Yu, F., Xiao, J., and Li, X. (2023). Virtual Screening–Based Discovery of AI-2 Quorum Sensing Inhibitors That Interact with an Allosteric Hydrophobic Site of LsrK and Their Functional Evaluation. Front. Chem., 11. · DOI
- Zhao, X., Yu, Z., and Ding, T. (2020). Quorum-Sensing Regulation of Antimicrobial Resistance in Bacteria. Microorganisms, 8. · DOI · Paper page
- Yin, 2022, 3-Phenylpropan-1-Amine Enhanced Susceptibility of Serratia Marcescens to Ofloxacin by Occluding Quorum Sensing, Microbiol. Spectr., 10, e01829-22, 10.1128/spectrum.01829-22 · DOI
- Hoang, 2023, Modulation of the Bacterial Virulence and Resistance by Well-Known European Medicinal Herbs, J. Ethnopharmacol., 312, 116484, 10.1016/j.jep.2023.116484 · DOI
- Patel, 2025, Combatting Antibiotic Resistance by Exploring the Promise of Quorum Quenching in Targeting Bacterial Virulence, Microbe, 6, 100224, 10.1016/j.microb.2024.100224 · DOI
- Qin, X., Vila-Sanjurjo, C., Singh, R., Philipp, B., and Goycoolea, F.M. (2020). Screening of Bacterial Quorum Sensing Inhibitors in a Vibrio Fischeri LuxR-Based Synthetic Fluorescent E. Coli Biosensor. Pharmaceuticals, 13. · DOI
- Mirpour, M., and Zahmatkesh, H. (2024). Ketoprofen Attenuates Las/Rhl Quorum-Sensing (QS) Systems of Pseudomonas aeruginosa: Molecular and Docking Studies. Mol. Biol. Rep., 51. · DOI
- Saeed, A., Ali, H., Yasmin, A., Baig, M., Ullah, A., Kazmi, A., Ahmed, M.A., Albadrani, G.M., El-Demerdash, F.M., and Bibi, M. (2023). Unveiling the Antibiotic Susceptibility and Antimicrobial Potential of Bacteria from Human Breast Milk of Pakistani Women: An Exploratory Study. BioMed Res. Int., 2023. · DOI
- Lin, 2021, Probiotic Bacillus Affects Enterococcus faecalis Antibiotic Resistance Transfer by Interfering with Pheromone Signaling Cascades, Appl. Environ. Microbiol., 87, e00442-21, 10.1128/AEM.00442-21 · DOI
- Khalil, T., Okla, M.K., Al-Qahtani, W.H., Ali, F., Zahra, M., Shakeela, Q., Ahmed, S., Akhtar, N., AbdElgawad, H., and Asif, R. (2024). Tracing Probiotic Producing Bacterial Species from Gut of Buffalo (Bubalus bubalis), South-East-Asia. Braz. J. Biol., 84. · doi:10.1590/1519-6984.259094
- Wang, S., Zhang, M., Yu, L., Tian, F., Lu, W., Wang, G., Chen, W., Wang, J., and Zhai, Q. (2022). Evaluation of the Potential Protective Effects of Lactobacillus Strains Against Helicobacter pylori Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial. Can. J. Infect. Dis. Med. Microbiol., 2022. · DOI
- Pike, 2021, Exploring the Genomic Diversity and Antimicrobial Susceptibility of Bifidobacterium pseudocatenulatum in a Vietnamese Population, Microbiol. Spectr., 9, e00526-21, 10.1128/Spectrum.00526-21 · DOI
- Wu, Y., Wang, Y., Hu, A., Shu, X., Huang, W., Liu, J., Wang, B., Zhang, R., Yue, M., and Yang, C. (2022). Lactobacillus plantarum-Derived Postbiotics Prevent Salmonella-Induced Neurological Dysfunctions by Modulating Gut–Brain Axis in Mice. Front. Nutr., 9. · DOI
- Badr, 2021, Effects of the Prebiotic Lactoferrin on Multidrug-Resistant Escherichia coli Infections in Broiler Chickens, Vet. World, 14, 2197, 10.14202/vetworld.2021.2197-2205 · DOI
- Kaczmarczyk, M., Szulińska, M., Łoniewski, I., Kręgielska-Narożna, M., Skonieczna-Żydecka, K., Kosciolek, T., Bezshapkin, V., and Bogdański, P. (2022). Treatment with Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women with Obesity: A Randomized, Double-Blind, Placebo-Controlled Study. Front. Cell. Infect. Microbiol., 12. · DOI
- Kumar, 2022, In Vitro Screening for Potential Probiotic Properties of Ligilactobacillus salivarius Isolated from Cattle Calves, Curr. Res. Biotechnol., 4, 275, 10.1016/j.crbiot.2022.06.001 · DOI
- Abraham, 2022, Bacillus Strains from the Ovaries of Swiss Albino Mice (Mus musculus): Deciphering of Probiotic Potential through an in Vitro Approach, Biomedicine, 42, 1200, 10.51248/.v42i6.2302 · DOI
- Rodríguez-Sorrento, A., Castillejos, L., López-Colom, P., Cifuentes-Orjuela, G., Rodríguez-Palmero, M., Moreno-Muñoz, J.A., and Martín-Orúe, S.M. (2020). Effects of Bifidobacterium longum Subsp. Infantis CECT 7210 and Lactobacillus rhamnosus HN001, Combined or Not with Oligofructose-Enriched Inulin, on Weaned Pigs Orally Challenged with Salmonella typhimurium. Front. Microbiol., 11. · DOI
- Lockyer, 2019, Prebiotics—An Added Benefit of Some Fibre Types, Nutr. Bull., 44, 74, 10.1111/nbu.12366 · DOI
- Huang, F.-C., and Huang, S.-C. (2021). The Combined Beneficial Effects of Postbiotic Butyrate on Active Vitamin D3-Orchestrated Innate Immunity to Salmonella Colitis. Biomedicines, 9. · DOI
- Salemi, 2023, Lactobacillus rhamnosus GG Cell-Free Supernatant as a Novel Anti-Cancer Adjuvant, J. Transl. Med., 21, 195, 10.1186/s12967-023-04036-3 · DOI
- Huang, 2020, Beneficial Effect of Probiotics on Pseudomonas aeruginosa–Infected Intestinal Epithelial Cells through Inflammatory IL-8 and Antimicrobial Peptide Human Beta-Defensin-2 Modulation, Innate Immun., 26, 592, 10.1177/1753425920959410 · DOI
- Gu, 2023, Characterization of Leuconostoc mesenteroides MJM60376 as an Oral Probiotic and Its Antibiofilm Activity, Mol. Oral Microbiol., 38, 145, 10.1111/omi.12397 · DOI
- Zhang, Q., Zhao, W., Zhao, Y., Duan, S., Liu, W.-H., Zhang, C., Sun, S., Wang, T., Wang, X., and Hung, W.-L. (2022). In Vitro Study of Bifidobacterium lactis BL-99 with Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. Front. Nutr., 9. · DOI
- Geng, 2023, In Vitro Screening of Synbiotics Composed of Lactobacillus Paracasei VL8 and Various Prebiotics and Mechanism to Inhibits the Growth of Salmonella typhimurium, LWT, 180, 114666, 10.1016/j.lwt.2023.114666 · DOI
- Piatek, J., Krauss, H., Ciechelska-Rybarczyk, A., Bernatek, M., Wojtyla-Buciora, P., and Sommermeyer, H. (2020). In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters. Int. J. Environ. Res. Public Health, 17. · DOI
- Daca, 2020, Therapeutic Methods of Gut Microbiota Modification in Colorectal Cancer Management—Fecal Microbiota Transplantation, Prebiotics, Probiotics, and Synbiotics, Gut Microbes, 11, 1518, 10.1080/19490976.2020.1764309 · DOI · Paper page
- Sommermeyer, H., Pituch, H.M., Wultanska, D., Wojtyla-Buciora, P., Piatek, J., and Bernatek, M. (2021). Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics—An Option for Diarrhea Management in Nursing Facilities. Int. J. Environ. Res. Public Health, 18. · DOI
- Gugjoo, 2023, Mesenchymal Stem Cells: A Promising Antimicrobial Therapy in Veterinary Medicine, Microb. Pathog., 182, 106234, 10.1016/j.micpath.2023.106234 · DOI
- Cardoso, 2022, Dissecting the Relationship between Antimicrobial Peptides and Mesenchymal Stem Cells, Pharmacol. Ther., 233, 108021, 10.1016/j.pharmthera.2021.108021 · DOI
- Gupta, 2023, CXCR4 Expression Is Elevated in TNBC Patient Derived Samples and Z-Guggulsterone Abrogates Tumor Progression by Targeting CXCL12/CXCR4 Signaling Axis in Preclinical Breast Cancer Model, Environ. Res., 232, 116335, 10.1016/j.envres.2023.116335 · DOI
- Chinipardaz, Z., Zhong, J.M., and Yang, S. (2022). Regulation of LL-37 in Bone and Periodontium Regeneration. Life, 12. · DOI
- McCulloch, 2022, Towards Efficient Immunotherapy for Bacterial Infection, Trends Microbiol., 30, 158, 10.1016/j.tim.2021.05.005 · DOI
- Ye, 2024, Influencing Immunity: Role of Extracellular Vesicles in Tumor Immune Checkpoint Dynamics, Exp. Mol. Med., 56, 2365, 10.1038/s12276-024-01340-w · DOI
- Pang, 2019, Sono-immunotherapeutic Nanocapturer to Combat Multidrug-resistant Bacterial Infections, Adv. Mater., 31, 1902530, 10.1002/adma.201902530 · DOI · Paper page
- Wang, 2022, Branched AuAg Nanoparticles Coated by Metal–Phenolic Networks for Treating Bacteria-Induced Periodontitis via Photothermal Antibacterial and Immunotherapy, Mater. Des., 224, 111401, 10.1016/j.matdes.2022.111401 · DOI
- Mitton, 2008, A Brief Overview of Photodynamic Therapy in Europe, Photodiagn. Photodyn. Ther., 5, 103, 10.1016/j.pdpdt.2008.04.004 · DOI
- Shih, Y.-H., Yu, C.-C., Chang, K.-C., Tseng, Y.-H., Li, P.-J., Hsia, S.-M., Chiu, K.-C., and Shieh, T.-M. (2022). Synergistic Effect of Combination of a Temoporfin-Based Photodynamic Therapy with Potassium Iodide or Antibacterial Agents on Oral Disease Pathogens In Vitro. Pharmaceuticals, 15. · DOI
- Liu, 2022, Synergistic Gentamicin-Photodynamic Therapy against Resistant Bacteria in Burn Wound Infections, Photodiagn. Photodyn. Ther., 39, 103034, 10.1016/j.pdpdt.2022.103034 · DOI
- Liu, 2020, Synergistic Antimicrobial Effects of Photodynamic Antimicrobial Chemotherapy and Gentamicin on Staphylococcus aureus and Multidrug-Resistant Staphylococcus aureus, Photodiagn. Photodyn. Ther., 30, 101703, 10.1016/j.pdpdt.2020.101703 · DOI
- Yang, 2013, Photodynamic Inactivation of Chlorin E6-loaded CTAB-liposomes against Candida albicans, Lasers Surg. Med., 45, 175, 10.1002/lsm.22124 · DOI
- Wainwright, 2017, Photoantimicrobials—Are We Afraid of the Light?, Lancet Infect. Dis., 17, e49, 10.1016/S1473-3099(16)30268-7 · DOI · Paper page
- Sperandio, 2013, Antimicrobial Photodynamic Therapy to Kill Gram-Negative Bacteria, Recent Pat. Anti-Infect. Drug Discov., 8, 108, 10.2174/1574891X113089990012 · DOI · Paper page
- Li, 2013, Effects of 5-Aminolevulinic Acid–Mediated Photodynamic Therapy on Antibiotic-Resistant Staphylococcal Biofilm: An in Vitro Study, J. Surg. Res., 184, 1013, 10.1016/j.jss.2013.03.094 · DOI
- Vasconcelos, 2017, Photodynamic Therapy Using. Chloro-Aluminum Phthalocyanine Decreases Inflammatory Response in an Experimental Rat. Periodontal Disease Model, J. Photochem. Photobiol. B Biol., 167, 208, 10.1016/j.jphotobiol.2016.12.031 · DOI
- Kamruzzaman, M., and Iredell, J.R. (2020). CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae. Front. Microbiol., 10. · DOI
- Tao, 2022, Association of CRISPR-Cas System with the Antibiotic Resistance and Virulence Genes in Nosocomial Isolates of Enterococcus, Infect. Drug Resist., 15, 6939, 10.2147/IDR.S388354 · DOI
- Greene, 2018, CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense, Trends Biotechnol., 36, 127, 10.1016/j.tibtech.2017.10.021 · DOI
- Wu, Y., Battalapalli, D., Hakeem, M.J., Selamneni, V., Zhang, P., Draz, M.S., and Ruan, Z. (2021). Engineered CRISPR-Cas Systems for the Detection and Control of Antibiotic-Resistant Infections. J. Nanobiotechnol., 19. · DOI · Paper page
- Pursey, 2022, CRISPR-Cas Is Associated with Fewer Antibiotic Resistance Genes in Bacterial Pathogens, Phil. Trans. R. Soc. B, 377, 20200464, 10.1098/rstb.2020.0464 · DOI · Paper page
- Wang, 2022, CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI, Microbiol. Spectr., 10, e00829-22, 10.1128/spectrum.00829-22 · DOI
- Gholizadeh, P., Aghazadeh, M., Ghotaslou, R., Rezaee, M.A., Pirzadeh, T., Cui, L., Watanabe, S., Feizi, H., Kadkhoda, H., and Kafil, H.S. (2021). Role of CRISPR-Cas System on Antibiotic Resistance Patterns of Enterococcus faecalis. Ann. Clin. Microbiol. Antimicrob., 20. · DOI
- Murugesan, 2022, Analysis of CRISPR–Cas System and Antimicrobial Resistance in Staphylococcus Coagulans Isolates, Lett. Appl. Microbiol., 75, 126, 10.1111/lam.13713 · doi:10.1111/lam.13713
- Alduhaidhawi, 2022, Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in Enterococcus faecalis and Enterococcus faecium Collected from Hospital Wastewater, Infect. Drug Resist., 15, 1143, 10.2147/IDR.S358248 · DOI · Paper page
- Sahu, 2023, Bacteriophages Concept and Applications: A Review on Phage Therapy, Curr. Pharm. Biotechnol., 24, 1245, 10.2174/1389201024666221104142457 · DOI
- Ling, 2022, Recent Advances in Bacteriophage-Based Therapeutics: Insight into the Post-Antibiotic Era, Acta Pharm. Sin. B, 12, 4348, 10.1016/j.apsb.2022.05.007 · DOI · Paper page
- Dufour, 2017, The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin than by β-Lactams, Clin. Infect. Dis., 64, 1582, 10.1093/cid/cix184 · DOI · Paper page
- Oechslin, 2017, Synergistic Interaction between Phage Therapy and Antibiotics Clears Pseudomonas aeruginosa Infection in Endocarditis and Reduces Virulence, J. Infect. Dis., 215, 703
- Leung, 2017, Modeling the Synergistic Elimination of Bacteria by Phage and the Innate Immune System, J. Theor. Biol., 429, 241, 10.1016/j.jtbi.2017.06.037 · DOI
- Durbas, 2022, Phage Therapy: An Old Concept with New Perspectives, J. Appl. Pharm. Sci., 12, 027
- Enault, 2017, Phages Rarely Encode Antibiotic Resistance Genes: A Cautionary Tale for Virome Analyses, ISME J., 11, 237, 10.1038/ismej.2016.90 · DOI · Paper page
- Suhas, 2022, Structure, Function and Mechanistic Aspects of Scorpion Venom Peptides—A Boon for the Development of Novel Therapeutics, Eur. J. Med. Chem. Rep., 6, 100068
- Yacoub, T., Rima, M., Karam, M., Sabatier, J.-M., and Fajloun, Z. (2020). Antimicrobials from Venomous Animals: An Overview. Molecules, 25. · DOI
- Ageitos, L., Torres, M.D.T., and De La Fuente-Nunez, C. (2022). Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond. Int. J. Mol. Sci., 23. · DOI
- Li, 2019, Peptides with Therapeutic Potential in the Venom of the Scorpion Buthus martensii Karsch, Peptides, 115, 43, 10.1016/j.peptides.2019.02.009 · DOI
- Zerouti, 2019, Nontoxic Fraction of Scorpion Venom Reduces Bacterial Growth and Inflammatory Response in a Mouse Model of Infection, Toxin Rev., 40, 1
- Ahmadi, S., Knerr, J.M., Argemi, L., Bordon, K.C.F., Pucca, M.B., Cerni, F.A., Arantes, E.C., Çalışkan, F., and Laustsen, A.H. (2020). Scorpion Venom: Detriments and Benefits. Biomedicines, 8. · DOI · Paper page
- Cesa-Luna, C., Muñoz-Rojas, J., Saab-Rincon, G., Baez, A., Morales-García, Y.E., Juárez-González, V.R., and Quintero-Hernández, V. (2019). Structural Characterization of Scorpion Peptides and Their Bactericidal Activity against Clinical Isolates of Multidrug-Resistant Bacteria. PLoS ONE, 14. · doi:10.1371/journal.pone.0222438
- Teerapo, K., Roytrakul, S., Sistayanarain, A., and Kunthalert, D. (2019). A Scorpion Venom Peptide Derivative BmKn‑22 with Potent Antibiofilm Activity against Pseudomonas aeruginosa. PLoS ONE, 14. · DOI
- Shi, P., Xie, S., Yang, J., Zhang, Y., Han, S., Su, S., and Yao, H. (2022). Pharmacological Effects and Mechanisms of Bee Venom and Its Main Components: Recent Progress and Perspective. Front. Pharmacol., 13. · DOI
- Tiwari, 2022, Melittin: A Natural Peptide with Expanded Therapeutic Applications, Nat. Prod. J., 12, 13
- El-Seedi, H., El-Wahed, A.A., Yosri, N., Musharraf, S.G., Chen, L., Moustafa, M., Zou, X., Al-Mousawi, S., Guo, Z., and Khatib, A. (2020). Antimicrobial Properties of Apis mellifera’s Bee Venom. Toxins, 12. · DOI
- Hegazi, 2014, Evaluation of the Antibacterial Activity of Bee Venom from Different Sources, World Appl. Sci. J., 30, 266
- Fadl, 2018, Antibacterial and Antibiofilm Effects of Bee Venom from (Apis mellifera) on Multidrug-Resistant Bacteria (Mdrb), Al-Azhar J. Pharm. Sci., 58, 60, 10.21608/ajps.2018.46641 · DOI
- Choi, 2015, Melittin, a Honeybee Venom-Derived Antimicrobial Peptide, May Target Methicillin-Resistant Staphylococcus aureus, Mol. Med. Rep., 12, 6483, 10.3892/mmr.2015.4275 · DOI
- Oguiura, N., Corrêa, P.G., Rosmino, I.L., de Souza, A.O., and Pasqualoto, K.F.M. (2021). Antimicrobial Activity of Snake β-Defensins and Derived Peptides. Toxins, 14. · doi:10.3390/toxins14010001
- De Barros, E., Gonçalves, R.M., Cardoso, M.H., Santos, N.C., Franco, O.L., and Cândido, E.S. (2019). Snake Venom Cathelicidins as Natural Antimicrobial Peptides. Front. Pharmacol., 10. · DOI
- Blaylock, 2000, Antibacterial Properties of KwaZulu Natal Snake Venoms, Toxicon, 38, 1529, 10.1016/S0041-0101(00)00085-4 · doi:10.1016/s0041-0101(00)00085-4
- Dal Mas, C., Rossato, L., Shimizu, T., Oliveira, E.B.D., da Silva Júnior, P.I., Meis, J.F., Colombo, A.L., and Hayashi, M.A.F. (2019). Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen. Biomolecules, 9. · DOI · Paper page
- Bandeira, 2017, Antichagasic Effect of Crotalicidin, a Cathelicidin-like Vipericidin, Found in Crotalus durissus terrificus Rattlesnake’s Venom Gland, Parasitology, 145, 1059, 10.1017/S0031182017001846 · doi:10.1017/s0031182017001846
- Franco, 2013, Snake Venoms: Attractive Antimicrobial Proteinaceous Compounds for Therapeutic Purposes, Cell. Mol. Life Sci., 70, 4645, 10.1007/s00018-013-1345-x · DOI
- Guo, 2012, Past Decade Study of Snake Venom L-Amino Acid Oxidase, Toxicon, 60, 302, 10.1016/j.toxicon.2012.05.001 · DOI
- Oliveira, 2022, The Chemistry of Snake Venom and Its Medicinal Potential, Nat. Rev. Chem., 6, 451, 10.1038/s41570-022-00393-7 · DOI · Paper page
- Wang, Y.-J., Wang, L., Yang, H., Xiao, H., Farooq, A., Liu, Z., Hu, M., and Shi, X. (2016). The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria. Toxins, 8. · doi:10.3390/toxins8050119
- Abreu, 2017, Peptidomics of Acanthoscurria gomesiana Spider Venom Reveals New Toxins with Potential Antimicrobial Activity, J. Proteom., 151, 232, 10.1016/j.jprot.2016.07.012 · doi:10.1016/j.jprot.2016.07.012
- Wu, 2019, Spider Venom Peptides as Potential Drug Candidates Due to Their Anticancer and Antinociceptive Activities, J. Venom. Anim. Toxins Incl. Trop. Dis., 25, e146318, 10.1590/1678-9199-jvatitd-14-63-18 · DOI
- Gurrola, 2000, Hadrurin, a New Antimicrobial Peptide from the Venom of the Scorpion Hadrurus aztecus, Eur. J. Biochem., 267, 5023, 10.1046/j.1432-1327.2000.01556.x · DOI · Paper page
- Corzo, 2001, Characterization of Unique Amphipathic Antimicrobial Peptides from Venom of the Scorpion Pandinus Imperator, Biochem. J., 359, 35, 10.1042/bj3590035 · doi:10.1042/bj3590035
- Rodríguez, A., Villegas, E., Montoya-Rosales, A., Rivas-Santiago, B., and Corzo, G. (2014). Characterization of Antibacterial and Hemolytic Activity of Synthetic Pandinin 2 Variants and Their Inhibition against Mycobacterium tuberculosis. PLoS ONE, 9. · DOI
- Zeng, 2012, Characterization of BmKbpp, a Multifunctional Peptide from the Chinese Scorpion Mesobuthus martensii Karsch: Gaining Insight into a New Mechanism for the Functional Diversification of Scorpion Venom Peptides, Peptides, 33, 44, 10.1016/j.peptides.2011.11.012 · DOI
- Corzo, 2015, Peptides from the Scorpion Vaejovis punctatus with Broad Antimicrobial Activity, Peptides, 73, 51, 10.1016/j.peptides.2015.08.014 · DOI
- Guo, 2013, Two Peptides, TsAP-1 and TsAP-2, from the Venom of the Brazilian Yellow Scorpion, Tityus serrulatus: Evaluation of Their Antimicrobial and Anticancer Activities, Biochimie, 95, 1784, 10.1016/j.biochi.2013.06.003 · doi:10.1016/j.biochi.2013.06.003
- Cao, 2012, StCT2, a New Antibacterial Peptide Characterized from the Venom of the Scorpion Scorpiops tibetanus, Peptides, 36, 213, 10.1016/j.peptides.2012.04.010 · DOI
- Ratajczak, M., Kaminska, D., Matuszewska, E., Hołderna-Kedzia, E., Rogacki, J., and Matysiak, J. (2021). Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products. Molecules, 26. · DOI
- Pluta, 2020, Changes in the Expression of Antimicrobial Peptide Genes in Honey Bees (Apis mellifera) under the Influence of Various Pathogens, Ann. Parasitol., 66, 457
- Falcao, 2014, Vipericidins: A Novel Family of Cathelicidin-Related Peptides from the Venom Gland of South American Pit Vipers, Amino Acids, 46, 2561, 10.1007/s00726-014-1801-4 · DOI
- Blower, 2018, Cathelicidin Peptide Rescues G. mellonella Infected with B. Anthracis, Virulence, 9, 287, 10.1080/21505594.2017.1293227 · doi:10.1080/21505594.2017.1293227
- Creane, S.E., Carlile, S.R., Downey, D., Weldon, S., Dalton, J.P., and Taggart, C.C. (2021). The Impact of Lung Proteases on Snake-Derived Antimicrobial Peptides. Biomolecules, 11. · doi:10.3390/biom11081106
- Kuhn-Nentwig, L. (2021). Complex Precursor Structures of Cytolytic Cupiennins Identified in Spider Venom Gland Transcriptomes. Sci. Rep., 11. · doi:10.1038/s41598-021-83624-z
- Salimo, Z.M., Barros, A.L., Adrião, A.A., Rodrigues, A.M., Sartim, M.A., de Oliveira, I.S., Pucca, M.B., Baia-da-Silva, D.C., Monteiro, W.M., and de Melo, G.C. (2023). Toxins from Animal Venoms as a Potential Source of Antimalarials: A Comprehensive Review. Toxins, 15. · DOI
- Rodriguez, C., Carrasco, J., Bruner-Montero, G., Júnior, O.R.P., Gutiérrez, M., and Díaz-Ferguson, E. (2025). Components and Biological Activities of Venom from Lionfishes (Scorpaenidae: Pterois). Mar. Drugs, 23. · doi:10.3390/md23020055
- Shin, M.K., Hwang, I.-W., Kim, Y., Kim, S.T., Jang, W., Lee, S., Bang, W.Y., Bae, C.-H., and Sung, J.-S. (2020). Antibacterial and Anti-Inflammatory Effects of Novel Peptide Toxin from the Spider Pardosa astrigera. Antibiotics, 9. · doi:10.3390/antibiotics9070422
- Han, 2021, Chemical Modifications to Increase the Therapeutic Potential of Antimicrobial Peptides, Peptides, 146, 170666, 10.1016/j.peptides.2021.170666 · DOI · Paper page
- Carratalá, J.V., Serna, N., Villaverde, A., Vázquez, E., and Ferrer-Miralles, N. (2020). Nanostructured Antimicrobial Peptides: The Last Push towards Clinics. Biotechnol. Adv., 44. · DOI
- Bellotto, O., Semeraro, S., Bandiera, A., Tramer, F., Pavan, N., and Marchesan, S. (2022). Polymer Conjugates of Antimicrobial Peptides (AMPs) with D-Amino Acids (D-Aa): State of the Art and Future Opportunities. Pharmaceutics, 14. · DOI
- Tyagi, 2022, Development of Potential Proteasome Inhibitors against Mycobacterium tuberculosis, J. Biomol. Struct. Dyn., 40, 2189, 10.1080/07391102.2020.1835722 · doi:10.1080/07391102.2020.1835722
- Nazir, 2022, Stimuli-Sensitive Drug Delivery Systems for Site-Specific Antibiotic Release, Drug Discov. Today, 27, 1698, 10.1016/j.drudis.2022.02.014 · DOI · Paper page
- Kassinger, 2020, Biofilm Architecture: An Emerging Synthetic Biology Target, Synth. Syst. Biotechnol., 5, 1, 10.1016/j.synbio.2020.01.001 · DOI · Paper page
- Mukherjee, R., Vidic, J., Leal, E., da Costa, A.C., Prudencio, C.R., Raj, V.S., Chang, C.-M., and Pandey, R.P. (2023). Nanobiotics and the One Health Approach: Boosting the Fight Against Antimicrobial Resistance at the Nanoscale. Biomolecules, 13. · DOI
- Elfadil, 2022, Promising Advances in Nanobiotic-Based Formulations for Drug Specific Targeting Against Multidrug-Resistant Microbes and Biofilm-Associated Infections, Microb. Pathog., 170, 105721, 10.1016/j.micpath.2022.105721 · DOI
- Mohamed, 2021, Nanobiotic Formulations as Promising Advances for Combating MRSA Resistance: Susceptibilities and Post-Antibiotic Effects of Clindamycin, Doxycycline, and Linezolid, RSC Adv., 11, 39696, 10.1039/D1RA08639A · DOI
- Milewska, 2021, Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment, Int. J. Nanomed., 16, 6593, 10.2147/IJN.S323831 · DOI
- Chakraborty, N., Jha, D., Roy, I., Kumar, P., Gaurav, S.S., Marimuthu, K., Ng, O.-T., Lakshminarayanan, R., Verma, N.K., and Gautam, H.K. (2022). Nanobiotics against Antimicrobial Resistance: Harnessing the Power of Nanoscale Materials and Technologies. J. Nanobiotechnol., 20. · DOI · Paper page
- Makabenta, 2021, Nanomaterial-Based Therapeutics for Antibiotic-Resistant Bacterial Infections, Nat. Rev. Microbiol., 19, 23, 10.1038/s41579-020-0420-1 · DOI · Paper page
- Geersing, 2019, Folic Acid Conjugates of a Bleomycin Mimic for Selective Targeting of Folate Receptor Positive Cancer Cells, Bioorganic Med. Chem. Lett., 29, 1922, 10.1016/j.bmcl.2019.05.047 · doi:10.1016/j.bmcl.2019.05.047
- Tripathi, 2022, Recent Advances and Mechanistic Insights into Antibacterial Activity, Antibiofilm Activity, and Cytotoxicity of Silver Nanoparticles, ACS Appl. Bio Mater., 5, 1391, 10.1021/acsabm.2c00014 · DOI · Paper page
- Wagi, 2020, Bacterial Nanobiotic Potential, Green Process. Synth., 9, 203, 10.1515/gps-2020-0021 · doi:10.1515/gps-2020-0021
- Brown, 2012, Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus, Appl. Environ. Microbiol., 78, 2768, 10.1128/AEM.06513-11 · DOI · Paper page
- Okkeh, M., Bloise, N., Restivo, E., De Vita, L., Pallavicini, P., and Visai, L. (2021). Gold Nanoparticles: Can. They Be the Next Magic. Bullet for Multidrug-Resistant Bacteria?. Nanomaterials, 11. · DOI
- Cheng, 2022, pH-Triggered Size-Tunable Silver Nanoparticles: Targeted Aggregation for Effective Bacterial Infection Therapy, Small, 18, 2200915, 10.1002/smll.202200915 · DOI · Paper page
- Mamun, M.M., Sorinolu, A.J., Munir, M., and Vejerano, E.P. (2021). Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance. Front. Chem., 9. · DOI
- Chung, 2013, A Magneto-DNA Nanoparticle System for Rapid Detection and Phenotyping of Bacteria, Nat. Nanotechnol., 8, 369, 10.1038/nnano.2013.70 · DOI · Paper page
- Kulshrestha, 2016, Calcium Fluoride Nanoparticles Induced Suppression of Streptococcus Mutans Biofilm: An In Vitro and In Vivo Approach, Appl. Microbiol. Biotechnol., 100, 1901, 10.1007/s00253-015-7154-4 · DOI
- Wang, 2021, Liposome as a Delivery System for the Treatment of Biofilm-mediated Infections, J. Appl. Microbiol., 131, 2626, 10.1111/jam.15053 · DOI
- Cano, A., Ettcheto, M., Espina, M., López-Machado, A., Cajal, Y., Rabanal, F., Sánchez-López, E., Camins, A., García, M.L., and Souto, E.B. (2020). State-of-the-Art Polymeric Nanoparticles as Promising Therapeutic Tools against Human Bacterial Infections. J. Nanobiotechnol., 18. · DOI
- Forier, 2014, Lipid and Polymer Nanoparticles for Drug Delivery to Bacterial Biofilms, J. Control. Release, 190, 607, 10.1016/j.jconrel.2014.03.055 · DOI · Paper page
- Rajendiran, K., Zhao, Z., Pei, D.-S., and Fu, A. (2019). Antimicrobial Activity and Mechanism of Functionalized Quantum Dots. Polymers, 11. · DOI
- Courtney, 2016, Photoexcited Quantum Dots for Killing Multidrug-Resistant Bacteria, Nature Mater., 15, 529, 10.1038/nmat4542 · DOI · Paper page
- Kalhapure, 2015, Nanoengineered Drug Delivery Systems for Enhancing Antibiotic Therapy, J. Pharm. Sci., 104, 872, 10.1002/jps.24298 · DOI · Paper page
- Gupta, 2024, Construction, Features and Regulatory Aspects of Organ-Chip for Drug Delivery Applications: Advances and Prospective, Curr. Pharm. Des., 30, 1952, 10.2174/0113816128305296240523112043 · DOI
- Lazar, V., Oprea, E., and Ditu, L. (2023). Resistance, Tolerance, Virulence and Bacterial Pathogen Fitness—Current State and Envisioned Solutions for the near Future. Pathogens, 12. · DOI
- Kulchar, R.J., Singh, R., Ding, S., Alexander, E., Leong, K.W., and Daniell, H. (2023). Delivery of Biologics: Topical Administration. Biomaterials, 302. · DOI
- Aslam, 2018, Antibiotic Resistance: A Rundown of a Global Crisis, Infect. Drug Resist., 11, 1645, 10.2147/IDR.S173867 · DOI · Paper page
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Elshobary, M. E., Badawy, N. K., Ashraf, Y., Zatioun, A. A., Masriya, H. H., Ammar, M. M., Mohamed, N. A., Mourad, S., & Assy, A. M.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2025-03-12
- Volume
- 18
- Issue
- 3
- Pages
- 402
- ISSN
- 1424-8247
- Cited by
- 268
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.